Asianet Newsable on MSN
Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making
The company said its oral treatment fully normalized pain and sharply reduced inflammation in preclinical studies, ...
Mira Pharmaceuticals MIRA stock jumped 70% after-hours on preclinical data showing Mira-55 outperformed morphine in pain relief and inflammation reduction.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback